Literature DB >> 201354

Avoidance of vascular complications associated with the use of dopamine.

J B Stetson, G P Reading.   

Abstract

Dopamine, dihydroxyphenylethylamine has three distinct actions depending on dosage. Low doses in the range of 1-2 mcg/kg/min result in vasodilatation. Medium doses of 2-10 mcg/kg/min increase cardiac output due to beta adrenergic action, while above 10 mcg/kg/min a potent vasoconstrictor effect predominates. Because of this last action great care must be used to avoid extravasation of infusions of dopamine directly into the tissue. Dopamine is a very useful agent but carries great potential to do local damage. Administration through a catheter placed into a large vein is recommended. Should extravasation occur, prompt infiltration of the area with phentolamine and a local anaesthetic, local cooling and regional sympathetic block may reduce the damage. The case is reported of a patient who suffered extensive necrosis in the forearm following local extravasation of dopamine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201354     DOI: 10.1007/bf03006717

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  8 in total

1.  Pedal gangrene associated with the use of dopamine.

Authors:  C S Alexander; Y Sako; E Mikulic
Journal:  N Engl J Med       Date:  1975-09-18       Impact factor: 91.245

2.  SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE.

Authors:  L I GOLDBERG; R H MCDONALD; A M ZIMMERMAN
Journal:  N Engl J Med       Date:  1963-11-14       Impact factor: 91.245

3.  Letter: Dopamine gangrene.

Authors:  S I Greene; J W Smith
Journal:  N Engl J Med       Date:  1976-01-08       Impact factor: 91.245

Review 4.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

Review 5.  The use and misuse of pressor agents.

Authors:  N T Smith; A N Corbascio
Journal:  Anesthesiology       Date:  1970-07       Impact factor: 7.892

6.  Effectiveness of dopamine in patients with cardiogenic shock.

Authors:  J Holzer; J S Karliner; R A O'Rourke; W Pitt; J Ross
Journal:  Am J Cardiol       Date:  1973-07       Impact factor: 2.778

7.  Intravenous dopamine in the treatment of myocardial dysfunction after open-heart surgery.

Authors:  R Rosenblum; J Frieden
Journal:  Am Heart J       Date:  1972-06       Impact factor: 4.749

8.  Dopamine in the treatment of hypotension and shock.

Authors:  K L MacCannell; J L McNay; M B Meyer; L I Goldberg
Journal:  N Engl J Med       Date:  1966-12-22       Impact factor: 91.245

  8 in total
  4 in total

1.  Management of neonatal posterolateral diaphragmatic hernia.

Authors:  U R Nair; A Entress; D R Walker
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

2.  Dopamine infusion for the treatment of myocardial dysfunction associated with a persistent transitional circulation.

Authors:  G I Fiddler; R Chatrath; G J Williams; D R Walker; O Scott
Journal:  Arch Dis Child       Date:  1980-03       Impact factor: 3.791

3.  Consequences of peripheral chemoreflex inhibition with low-dose dopamine in humans.

Authors:  Piotr Niewinski; Stanislaw Tubek; Waldemar Banasiak; Julian F R Paton; Piotr Ponikowski
Journal:  J Physiol       Date:  2014-01-06       Impact factor: 5.182

4.  Risk Factors of Vasopressor-Induced Symmetrical Peripheral Gangrene.

Authors:  Jung Woo Kwon; Min Ki Hong; Bo Young Park
Journal:  Ann Plast Surg       Date:  2018-06       Impact factor: 1.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.